From: Thoracic surgery in the COVID-19 era: an Italian university hospital experience
Gender | Age | Time from COVID to Surgery (days) | LOS (days) | Comorbidity | COVID severity | COVID-19 Duration (D) | Histology | Surgical procedure | Perioperative complications |
---|---|---|---|---|---|---|---|---|---|
M | 43 | 75 | 3 | GERD, COPD | Dyspnoea | 21 | Invasive adenocarcinoma | RUL sub-anatomical resection | None |
M | 54 | 39 | 4 | none | Dyspnoea | 14 | thymoma B2 | Thymectomy | None |
M | 65 | 48 | 3 | AF, DVT, Arterial Hypertension | Bilateral Interstitial Pneumonia and respiratory failure requiring NIV | 20 | Invasive adenocarcinoma | LIL lobectomy | None |
M | 50 | 126 | 6 | GERD and arrhythmia of unknown origin | Respiratory failure requiring Oxygen supplementation | 28 | Invasive adenocarcinoma | RIL lobectomy | None |
F | 57 | 111 | 7 | thyropathy, nonalcoholic steatosis hepatic disease, obesity, cerebral meningioma | Bilateral Interstitial Pneumonia and respiratory failure requiring NIV | 27 | Hodgkin Lymphoma | mediastinal biopsy | None |
F | 65 | 54 | 2 | Thyropathy | Dyspnoea | 14 | Squamous cell carcinoma | RUL lobectomy | None |
F | 67 | 96 | 6 | COPD, Thyropathy, osteoporosis, internal carotid stenosis | Bilateral Interstitial Pneumonia and respiratory failure requiring NIV | 23 | Invasive adenocarcinoma | RUL sub-anatomical resection and LVRS | None |